# AVATR - Arteriovenous Access Thrombosis Removal With CAPERE Thrombectomy System

> **NCT04494035** · NA · TERMINATED · sponsor: **Medtronic Endovascular** · enrollment: 7 (actual)

## Conditions studied

- Arteriovenous Graft Thrombosis

## Interventions

- **DEVICE:** CAPERE Thrombectomy System

## Key facts

- **NCT ID:** NCT04494035
- **Lead sponsor:** Medtronic Endovascular
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-01-14
- **Primary completion:** 2020-10-23
- **Final completion:** 2020-10-23
- **Target enrollment:** 7 (ACTUAL)
- **Why stopped:** Sponsor change
- **Last updated:** 2022-09-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04494035

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04494035, "AVATR - Arteriovenous Access Thrombosis Removal With CAPERE Thrombectomy System". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04494035. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*